fMRI for BPS: A Descriptive Study of Findings and Symptoms
The goal of this observational study is to investigate the relationship between functional magnetic resonance imaging (fMRI) findings of the brain and symptom presentation in patients with bladder pain syndrome (BPS). The main questions it aims to answer are: 1. To explore the distribution characteristics of fMRI imagi
| Condition(s) | Bladder Pain Syndrome |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The goal of this observational study is to investigate the relationship between functional magnetic resonance imaging (fMRI) findings of the brain and symptom presentation in patients with bladder pain syndrome (BPS). The main questions it aims to answer are: 1. To explore the distribution characteristics of fMRI imaging and possible target lesions in the patient population. 2. To provide appropriate clues and evidence for etiological exploration and therapeutic targeting of BPS. Participants will undergo fMRI as well as other routine laboratory tests and queries. |
| Who can participate | Inclusion Criteria for BPS group: 1. Be 18 years of age or older and female; 2. Be diagnosed with BPS (persistent or recurrent pain in the bladder area accompanied by at least one other symptom, such as increased pain when the bladder is full, and frequent urination during the day and/or at night, according to the current diagnostic criteria and clinical guidelines, without any of the conditions listed in the "Exclusion Criteria" below); 3. Persistence of symptoms for more than 6 months; 4. Visual analogue scale (VAS) of pain ≥ 4; 5. O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q) score of 12 or more, with pain and nocturia domain scores \>2; 6. Pelvic Pain and Urgency/Frequency Patient Symptom Scale (PUF) \>13; 7. No history of cystoscopy within 2 years. Exclusion Criteria for BPS |
| Ages | 18 Years |
| Sex | Female |
| Lead sponsor | RenJi Hospital |
| Locations | Shanghai, Shanghai Municipality, China |
| Start date | 2024-03-01 |
| NCT ID | NCT06294951 |
| Official listing | https://clinicaltrials.gov/study/NCT06294951 |